Clinical Trials · NCT00622323
Post Marketing Surveillance Study of Byetta ™ (Exenatide) Use Among Filipino Patients
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- AstraZeneca
- Enrollment
- 41
- Start date
- Feb 2008
- Locations
- 3 sites, Philippines
- Primary endpoint
- To determine the proportion of patients experiencing an adverse event and a list of the experienced adverse events, that would occur among Filipino patients with type 2 diabetes and inadequate glycemic control treated with exenatide